Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Repetitive transcranial magnetic stimulation in the treatment of resistant depression: changes of specific neurotransmitter precursor amino acids

    Repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depression offers an alternative therapy, since more than every third patient is not responding to adequate antidepressive trea...

    F. Leblhuber, S. Geisler, D. Ehrlich, K. Steiner in Journal of Neural Transmission (2021)

  2. Article

    Open Access

    Treatment of patients with geriatric depression with repetitive transcranial magnetic stimulation

    Repetitive transcranial magnetic stimulation (rTMS) has become a useful tool to treat different neuropsychiatric conditions such as depression, dementia and extrapyramidal syndromes insufficiently responding t...

    F. Leblhuber, K. Steiner, Dietmar Fuchs in Journal of Neural Transmission (2019)

  3. No Access

    Article

    Homocysteine but not neopterin declines in demented patients on B vitamins

    Inflammation and immune system activation seem to play an important role in the development and progression of dementia. Hyperhomocysteinemia is common in various forms of dementia, and a significant relations...

    B. Frick, B. Gruber, K. Schroecksnadel, F. Leblhuber in Journal of Neural Transmission (2006)

  4. No Access

    Article

    Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum

     The aim of this study was to compare dopamine receptor binding affinities of all currently approved dopamine receptor agonist treatments for Parkinson’s disease (PD) in human brain tissue. α-Dihydroergocrypti...

    M. Gerlach, K. Double, T. Arzberger, F. Leblhuber in Journal of Neural Transmission (2003)

  5. No Access

    Article

    Treatment of chronic neuropathic pain after traumatic central cervical cord lesion with gabapentin

     Central cord syndrome may be associated with severe pain, resistant to conventional pain therapy regimens. Chronic pain may be a persistent problem in rehabilitation of spinal cord injuries. These pain syndro...

    H. Haller, F. Leblhuber, J. Trenkler, R. Schmidhammer in Journal of Neural Transmission (2003)

  6. No Access

    Article

    Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease

    Moderate hyperhomocysteinaemia has been linked to an increased risk for cardiovascular diseases. Increased homocysteine concentrations may follow folate depletion due to insufficient dietary intake of the vit...

    B. Widner, F. Leblhuber, B. Frick, A. Laich in Journal of Neural Transmission (2002)

  7. No Access

    Article

    Increased neopterin production and tryptophan degradation in advanced Parkinson's disease

    Large amounts of neopterin are produced by interferon-(IFN)-γ-stimulated human monocytes/macrophages, and increased neopterin concentrations indicate cellular immune activation. In parallel, IFN-γ induces ind...

    B. Widner, F. Leblhuber, D. Fuchs in Journal of Neural Transmission (2002)

  8. No Access

    Article

    Hyperhomocysteinemia in dementia

    Hyperhomocysteinemia is a strong risk factor for atherosclerotic vascular disease, and elevated serum homocysteine is correlated with vitamin B deficiency. In this pilot study, significantly elevated homocyst...

    F. Leblhuber, J. Walli, E. Artner-Dworzak, K. Vrecko in Journal of Neural Transmission (2000)

  9. No Access

    Article

    Tryptophan degradation and immune activation in Alzheimer's disease

    Alzheimer's disease (AD) is likely associated with systemic immune activation. During immune response, interferon-gamma stimu-lates indoleamine 2,3-dioxygenase (IDO) converting tryptophan to N-formylkynurenin...

    B. Widner, F. Leblhuber, J. Walli, G. P. Tilz, U. Demel in Journal of Neural Transmission (2000)

  10. No Access

    Chapter

    Degradation of Tryptophan in Neurodegenerative Disorders

    In patients with neurodegenerative disorders, namely Alzheimer’s disease and Huntington’s disease, we compared serum concentrations of tryptophan, kynurenine and the kynurenine per tryptophan ratio with concen...

    B. Widner, F. Leblhuber, J. Walli, G. P. Tilz in Tryptophan, Serotonin, and Melatonin (1999)

  11. No Access

    Article

    Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia

    Quantitative clinicopathological correlation studies are one way to address the question of the relevance of morphological abnormalities in Alzheimer's dementia (AD). This paper summarizes results of the Vienn...

    C. Bancher, K. Jellinger, H. Lassmann in European Archives of Psychiatry and Clinic… (1996)

  12. No Access

    Article

    Age and sex differences of dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels in normal controls and Alzheimer's disease (AD)

    In 50 healthy subjects (23 female, 27 male, aged 18–81) and 24 patients with Alzheimer's disease (AD) (11 female, 13 male, aged 58–88) DHEAS and CRT plasma levels were studied. In normal subjects there was a c...

    F. Leblhuber, C. Neubauer, Marianne Peichl, F. Reisecker in Psychopharmacology (1993)

  13. No Access

    Article

    Long latency EMG responses in early diagnosis of Huntington's chorea

    In healthy subjects, 2 EMG responses of the thenar muscles can be distinguished, elicited by electrical stimulation of the median nerve during an isometric contraction: an early spinal response (M1) and a long la...

    F. Leblhuber, E. Windhager, F. Reisecker in European Archives of Psychiatry and Clinic… (1991)

  14. No Access

    Article

    Asterixis as a side effect of carbamazepine therapy

    A patient developed asterixis 13 weeks after starting a therapy with carbamazepine. Serum concentration of carbamazepine was within the therapeutic levels. Further factors which might have provoked asterixis w...

    H. Rittmannsberger, F. Leblhuber, R. Sommer in Klinische Wochenschrift (1991)

  15. No Access

    Article

    Single photon emission computed tomography in subjects at risk for Huntington's chorea

    F. Leblhuber, B. Brucker, F. Reisecker, F. Steinparz, E. Windhager in Journal of Neurology (1990)

  16. No Access

    Chapter

    Single photon emission computed tomography (SPECT) in Pick’s disease: two case reports

    The diagnostic value of SPECT in Pick’s disease is discussed on the basis of two cases. Personality changes predominated in both of them. Atrophy of the frontal and temporal lobes was seen on CT only in one of...

    Prim. Univ.-Doz. Dr. F. Reisecker, E. Laich in Alzheimer’s Disease. Epidemiology, Neuropa… (1990)

  17. No Access

    Article

    Single photon emission computed tomography (SPECT) in probable Huntington's chorea (HC)

    F. Leblhuber, B. Brucker, F. Reisecker in Journal of Neural Transmission - Parkinson… (1989)

  18. No Access

    Article

    Genetic linkage studies in hereditary motor and sensory neuropathies

    F. Leblhuber, F. Reisecker, W. R. Mayr, Alessandro Rossi in Journal of Neurology (1986)

  19. No Access

    Article

    Carpal tunnel syndrome: Neurographical parameters in different stages of median nerve compression

    In a series of 47 cases and 55 hands operated upon for carpal tunnel syndrome, the pre-operative electrodiagnostic findings have been compared retrospectively with the morphological findings within the carpal ...

    F. Leblhuber, F. Reisecker, A. Witzmann in Acta Neurochirurgica (1986)

  20. No Access

    Article

    Improvement of atactic syndrome after longer periods of alcohol abstinence

    F. Leblhuber, F. Reisecker, W. Pühringer in Journal of Neurology (1985)

previous disabled Page of 2